{"name":"Sung-Soo Park","slug":"sung-soo-park","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Antibody-Drug Conjugate","genericName":"Antibody-Drug Conjugate","slug":"antibody-drug-conjugate","indication":"Various types of cancer, including breast, lung, and ovarian cancer","status":"phase_2"},{"name":"Bispecific antibody","genericName":"Bispecific antibody","slug":"bispecific-antibody","indication":"Treatment of relapsed or refractory diffuse large B-cell lymphoma","status":"phase_2"}]}],"pipeline":[{"name":"Antibody-Drug Conjugate","genericName":"Antibody-Drug Conjugate","slug":"antibody-drug-conjugate","phase":"phase_2","mechanism":"Antibody-drug conjugates target specific cancer cells by binding to a protein on the cell surface, delivering a toxic payload to kill the cell.","indications":["Various types of cancer, including breast, lung, and ovarian cancer"],"catalyst":""},{"name":"Bispecific antibody","genericName":"Bispecific antibody","slug":"bispecific-antibody","phase":"phase_2","mechanism":"Binds to CD16A and CD19 to activate antibody-dependent cellular cytotoxicity and antibody-dependent cellular phagocytosis","indications":["Treatment of relapsed or refractory diffuse large B-cell lymphoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTFAtSGg5N0xWcFBGQTU5bTBJTVRlTFlJdWZKWkxPY3A2QnFaNE1QbmNXT0FBT21XRmVlU0t6RTJfQmZQU0J3cTVWNmlISQ?oc=5","date":"2026-03-08","type":"pipeline","source":"매일경제","summary":"Daewoong Pharmaceutical is one of the pharmaceutical companies with the strongest R&D capabiliti.. - 매일경제","headline":"Daewoong Pharmaceutical is one of the pharmaceutical companies with the strongest R&D capabiliti.. - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBQNklPdXhlb2ZaS3pRc2hCY0doS09yWkJxVE03OEZTb1QtTmV5MGYzcnJQTEUyUWdnOHg0RUZlbEJuUmNoTWFXNDBQd0hkWmk1Q0MtMGlEWHY4NENVeXBSTEQxVVRheVB1Uy1LYnJ30gFyQVVfeXFMUEViQnNBazkya3Rhd3hzWmxxRWtqZFNkMmxvUjk3MTY5OVROSl8waUh3aVB1RUpKcHNuOHUzdnVXaVF6cHJCMVVTVXVpTTgtcXRTYVpYVjc2UXZWa3V4Sm56RlN2X3A3bFJReGVWMXFTck53?oc=5","date":"2026-03-05","type":"pipeline","source":"koreabiomed.com","summary":"Korean pharma braces for governance reforms, CEO renewals in March meetings - koreabiomed.com","headline":"Korean pharma braces for governance reforms, CEO renewals in March meetings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOZTlHX2dVTXRNeUVxQmJDVnpEUlZjQnlvclRJLTBKVF9uTWpmcGZMZHRKM3k5VGtkNGRsTmJzZE8ySGRMZzZ2bldtNW1zMkRFTS0tLUFNN2xJSENkaGtZejJ4VndvcV94SEdKTWZNWEVFam1JZkd6YkdiMVpmR2ZpSEtWOGFWdXJteldOYy1NdHZ5QlRBbXIwMGJUTDl4UVRK?oc=5","date":"2026-01-09","type":"pipeline","source":"Seoul Economic Daily","summary":"Daewoong Pharma Opens 5th Innobear Startup Competition - Seoul Economic Daily","headline":"Daewoong Pharma Opens 5th Innobear Startup Competition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE9pNm1Jeno3YTlTcWV1SnNDWlpMYWh1VXIzN0ZldHNpS005YUNBX3BJOEk3TFhOQ3BkUnJqcFMwQmZDbWctNEhrcnVza2JYOVRpNjdTd29QWEdud2g2MXNGSUpac0NFM2Q5eU5lR0xSX3JYdmth?oc=5","date":"2025-04-18","type":"pipeline","source":"Businesskorea","summary":"Enblo’s Global Expansion Milestone: Daewoong Pharmaceutical’s Strategic Pursuit - Businesskorea","headline":"Enblo’s Global Expansion Milestone: Daewoong Pharmaceutical’s Strategic Pursuit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBNeWJySlNUUGdhTm11dkVQNXRJOWJVa0F3a3owMzdZYk12UU4yQzFIOUU0YXVYSnJBTmM4OWxIdjhZSEd4VTQ3OUV5LUo0MmEtVjlrSjB5a21vV181c3Uyd2ozeEE3NFNKQm1NWkh30gFyQVVfeXFMTVBZRC1HNXp3QU44b1Flc1Q2Y1RKalJuYm43ZU1Uc2xsMDJQaHF6dGFOM1kyTkRQbmpUTjh0aGJLZm5lU285VTJPLUx4MFdadm45b05QVGEtNEJlMXRabTN2SkhMU3V2aTlnOTdsdDNneEJn?oc=5","date":"2024-12-12","type":"pipeline","source":"koreabiomed.com","summary":"Daewoong Pharmaceutical leads consortium to develop once-monthly obesity drug - koreabiomed.com","headline":"Daewoong Pharmaceutical leads consortium to develop once-monthly obesity drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE45U2dPV25nNUdwNTVHamhUNVZ1UTlqdmM4WjBHYV9qaUFkeWNSd1JNdEtwdGgxRG5tczNTbXVmeG5mMEZrZE5lOEs4YkZxbGpBeE16aFlR?oc=5","date":"2024-09-13","type":"pipeline","source":"The Korea Herald","summary":"Daewoong unveils new Indonesian stem cell facility with GMP certification - The Korea Herald","headline":"Daewoong unveils new Indonesian stem cell facility with GMP certification","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE95cVVwbXpBSGJJMlVPd3NucnlsU1dJVU1mSHU5bFlwaGp3eXEzVVlvdUxUN0xlTXBOX240NVpMX3dDYmRCSURfamNwRmpLbmtvcmVMTGgxMHFxeG11QS1zX3RpMC1FRWl5N3o5MERB0gFyQVVfeXFMUFdBWGhDLXl4UnFmWEthM3JNWGlFWktobHVFNGVQdlVxMmtfMERtNkdBVFdNUE51T3NYMTVadlMtM2daNC1LTUtUWlRfUHEyQmEwdldGUzdJQzRYWDNQcFFoMjJOMnJXc0YwNWgzbDlUM29R?oc=5","date":"2024-07-15","type":"regulatory","source":"koreabiomed.com","summary":"Daewoong’s BTX receives approval in Argentina - koreabiomed.com","headline":"Daewoong’s BTX receives approval in Argentina","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBSYkJCX1JTS01udElwMDBHRFRiSmFfa0hNR3dNZlY3TllKYWthSWZGMVMxVFhma1ZNamxtMndVQlNqT01ha3Y4VmlfX1BNNVZsZ0VycXlPWGpEUmRjQWpzV2VTNzE3Yl9WN3Q2VmJ30gFyQVVfeXFMTWMzbHJHRmJNTVdUMER1UFhWZG1GdFIyRmpQUU5pYWVvNk5Wa1A4RkVNZk5ub2IxQnlpRkh1X3NMZTVRQWc5a3NWZFVrVDdoX2tMNUp6Y0VvX0U1aV9Zd3A2WUVXYmtiUXVodzhQYnpMUFB3?oc=5","date":"2024-06-19","type":"deal","source":"koreabiomed.com","summary":"Daewoong’s global partner launches BTX in Spain - koreabiomed.com","headline":"Daewoong’s global partner launches BTX in Spain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE84cUZiOGpYUkVrUDJoUFRCR21sMk1IUEc3THVxZDhheUJsUU53bzFmdnZ5VWpXR1lLcTBlWndMODBEd08yQldDSkdpczdXaXBCVlZfdTBzMDY2UVp5M3k4d2ZqUUJ2UHp5aDE3QUFn0gFyQVVfeXFMTVh6b2JHc2FFTW9weW9tU0QxOWZxNWNNVXVHdWZLbHc2SXdpb25MWDZ4WW5EaHF3SDItRzZTOFFhYllkbU5YMTJnbFczTjVFbjM3aFZLQjVrcWx3ZTctV0UxdzVtQncxSWtRUFJQTjJBS3NB?oc=5","date":"2024-06-12","type":"pipeline","source":"koreabiomed.com","summary":"Daewoong Pharmaceutical secures 12% BTX market share in US, 5 years after launch - koreabiomed.com","headline":"Daewoong Pharmaceutical secures 12% BTX market share in US, 5 years after launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTE9CZEpvZ3lrMm5KcWFuNEIwQl9Uc0ZScmNqUW9WTmt1cXpKb2tsakNJOUxJM0t6NjhTYzdrLW1HOHhzZVNMQmNjYWl5TQ?oc=5","date":"2024-03-29","type":"pipeline","source":"매일경제","summary":"Daewoong Pharmaceutical announced on the 29th that it held a board meeting on the 28th and voted on - 매일경제","headline":"Daewoong Pharmaceutical announced on the 29th that it held a board meeting on the 28th and voted on - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNdXl2eGRycGljR3h0RUh5aHRlem1Fa1JxalQ0YVBFSFRzbE1FU3R5NVE4LU95SkpRNEkxUDVta203bFZYelhCZlRKcGROTmdXQ01idmVGUXJldHJaUTdiMzVQRkdsMVNzd3dpMUtCX0lab01zREIwVV9SVHE4ZEdFTVIzLTN6RU83MGl6c09ZdjVrcW5UM1dmOA?oc=5","date":"2023-05-03","type":"pipeline","source":"Fierce Pharma","summary":"Daewoong plots new $74.6M factory in South Korea to pump out Botox rival - Fierce Pharma","headline":"Daewoong plots new $74.6M factory in South Korea to pump out Botox rival","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9reVlVMmN3Z0lDOVl2VU5xM3loNUlDMWkyeVd1SFBkaWx2SzZUUmdUQl8wQ0x6d1ZlLUF1S1d3aVB1d2MtNGhQa0RxLVNzZV9zZzhReThWUWFMeEJIYjRn?oc=5","date":"2019-03-29","type":"pipeline","source":"nature.com","summary":"Direct differentiation of bone marrow mononucleated cells into insulin producing cells using pancreatic β-cell-derived components - nature.com","headline":"Direct differentiation of bone marrow mononucleated cells into insulin producing cells using pancreatic β-cell-derived c","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}